NEW YORK, Aug. 31, 2023 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outlook Therapeutics, Inc. (“Outlook” or “the Company”) (NASDAQ: OTLK). Investors who purchased Outlook securities are encouraged…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.